Tilray Exchanges $72.9 Million In Convertible Notes For Shares At 42% Discount
Tilray Inc (NASDAQ: TLRY) has entered into an agreement to exchange $72.9 million worth of its convertible notes to that
Read more
Tilray
Tilray: Ladenburg Thalmann Remains Neutral Following Q3 Results
Monday night Tilray Inc (NASDAQ: TLRY) reported its third quarter results. Revenue for the quarter was $51.4 million, flat quarter
Read more
Palantir: The Future Of Organizational Data Science Because It Says So
Three weeks past its September 29, 2020 IPO, controversial data-science enterprise software company Palantir Technologies (NYSE: PLTR) is settling in
Read more
FOUR20 Acquires Funding For Litigation Against Tilray
It seems that previously reported litigation against Tilray Inc (NASDAQ: TLRY) will be proceeding following an extended period of time.
Read more
Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick
Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending September 19th. In the summary,
Read more
Tilray To Shut Down Natura Naturals Facility
Tilray Inc (NASDAQ: TLRY) will be closing a facility it acquired just last year as a means of cutting costs.
Read more
Tilray Announces $90.4 Million Financing
Ever been so strapped for cash that you announced a $90.4 million registered offering during the worst financial week in
Read more
Tilray Year End: Production Success Overshadowed By Impairments
Tilray Inc. (NASDAQ: TLRY), is off -50% since having published its year end financials after market March 2, down -$7.68
Read more
Tilray Sued By Four20 For $130 Million In Damages
It appears that the cannabis sector is just firing up in terms of lawsuits. Following iAnthus Capital’s announcement this morning
Read more
Tilray Hires New Chief Financial Officer, Chief Operating Officer
Tilray Inc (NASDAQ: TLRY) has bolstered its executive team this morning, with the appointment of both a new chief operating
Read more